Alkem

SQ Nebulized therapies

A nationwide, multicenter, cross-sectional, observational survey to assess physician's perspectives on prescription patterns, clinical decision-making factors, and the utilization of nebulized therapies in the management of respiratory conditions.

HCP initials*

Age *

City *

State *

Gender *

Male Female

Speciality *

General practitioner Consulting physician Pulmonologist Chest physician Pediatrician Other

The questions to be answered by the qualified medical practitioners. Following are questions:

How often do you prescribe nebulized treatments in your practice? (Scale: 1 = Never, 5 = Always) *

1 2 3 4 5

Which is the most common nebulizer prescribed in your patients? *

Jet Nebulizer Mesh Nebulizer Ultrasonic Nebulizer

Which of the following nebulized treatments do you commonly prescribe for your patients? (Select all that apply) *

Nebulized Budesonide Nebulized Fluticasone Nebulized Budesonide + Levosalbutamol Nebulized Glycopyrronium Nebulized Ipratropium + Levosalbutamol Nebulized Budesonide + Formoterol Other

For which respiratory conditions do you typically prescribe nebulization? (Select all that apply) *

Asthma COPD Acute Respiratory Infections Allergic Rhinitis Bronchiectasis Other

What factors influence your decision to prescribe nebulized therapy over other forms (e.g., inhalers)? (Select all that apply) *

Severity of the condition Patient Category (age, ability to use inhalers) Poor inhaler technique or adherence Rapid relief required Lack of alternative treatments Patient preference Other

In what percentage of patients do you observe significant improvement (e.g., relief of wheezing, shortness of breath) after nebulization? *

1-20% of patients 21-40% of patients 41-60% of patients 61-80% of patients 81-100% of patients

In your clinical experience, how frequently do patients fail to respond to nebulized therapy? *

Never Rarely Occasionally Frequently Always

In your experience, what is the most common challenge when prescribing nebulized therapy? *

Cost or insurance coverage Difficulty in patient adherence Lack of patient education on how to use nebulizer equipment Availability of nebulizer devices Limited clinical evidence or guidelines for some treatments Other

How often do you recommend nebulization as maintenance therapy versus acute exacerbation management? *

100% maintenance therapy 75% maintenance therapy / 25% acute exacerbations 50% maintenance therapy / 50% acute exacerbations 25% maintenance therapy / 75% acute exacerbations 100% acute exacerbations

How often do you prescribe nebulized therapy in pediatric patients compared to adults? *

100% pediatric patients 75% pediatric / 25% adult 50% pediatric / 50% adult 25% pediatric / 75% adult 100% adult patients

Do you typically monitor your patients' response to nebulized therapy during or after administration? *

Yes, during and after Yes, only after No, I rely on patient feedback No monitoring is done

What improvements would make nebulized treatments more effective or practical in your clinical practice? (Select all that apply) *

Better patient education on usage and adherence Improved nebulizer device design (e.g., smaller, more portable) Lower cost for both medications and devices Better treatment combinations with fewer side effects Easier-to-use nebulizers for elderly or pediatric patients Other

What percentage of your patients are shifted from handheld inhalers to nebulizers, and vice versa? *

From handheld inhalers to nebulizers:	From nebulizers to handheld inhalers:
0-10% 11-25% 26-50% 51-75% 76-100%	0-10% 11-25% 26-50% 51-75% 76-100%

What percentage of your patients require nebulization both in-clinic and at home? *

In-clinic nebulization:	Home nebulization:
0-10% 11-25% 26-50% 51-75% 76-100%	0-10% 11-25% 26-50% 51-75% 76-100%